Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study
TAR-200 在拒绝或不适合接受根治性治疗的肌层浸润性膀胱癌患者中的安全性、耐受性和初步疗效：一项 1 期研究
期刊:Journal of Urology
影响因子:6.8
doi:10.1097/JU.0000000000003195
Tyson, Mark D; Morris, David; Palou, Juan; Rodriguez, Oscar; Mir, Maria Carmen; Dickstein, Rian J; Guerrero-Ramos, Félix; Scarpato, Kristen R; Hafron, Jason M; Messing, Edward M; Cutie, Christopher J; Maffeo, John C; Raybold, Bradley; Chau, Albert; Stromberg, Katharine A; Keegan, Kirk A
